ERBB2 and cancer: These are prepared with anti-human epidermal growth factor receptor 2 (anti-HER2) scFv for cancer diagnostics and targeted therapeutics in HER2 overexpressing human breast carcinoma cells, SK-BR-3 and MCF7-C18 (Fig. 6) [88].